Ellevest Inc’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
6,725
+967
| +17% | +$182K | 0.15% | 104 |
|
|
2026
Q1 | $1.14M | Buy |
5,758
+1,310
| +29% | +$253K | 0.16% | 89 |
|
|
2025
Q4 | $818K | Buy |
4,448
+18
| +0.4% | +$3.16K | 0.11% | 130 |
|
|
2025
Q3 | $680K | Buy |
4,430
+22
| +0.5% | +$3.33K | 0.1% | 155 |
|
|
2025
Q2 | $616K | Sell |
4,408
-354
| -7% | -$49.6K | 0.1% | 155 |
|
|
2025
Q1 | $700K | Sell |
4,762
-3,285
| -41% | -$475K | 0.05% | 147 |
|
|
2024
Q4 | $1.05M | Sell |
8,047
-2,540
| -24% | -$356K | 0.06% | 99 |
|
|
2024
Q3 | $1.65M | Sell |
10,587
-436
| -4% | -$70.4K | 0.09% | 67 |
|
|
2024
Q2 | $1.72M | Buy |
11,023
+2,172
| +25% | +$327K | 0.1% | 58 |
|
|
2024
Q1 | $1.2M | Buy |
8,851
+921
| +12% | +$122K | 0.07% | 80 |
|
|
2023
Q4 | $1.07M | Sell |
7,930
-265
| -3% | -$34.4K | 0.07% | 78 |
|
|
2023
Q3 | $1.11M | Buy |
8,195
+676
| +9% | +$92.3K | 0.09% | 62 |
|
|
2023
Q2 | $1.08M | Buy |
7,519
+143
| +2% | +$21K | 0.08% | 64 |
|
|
2023
Q1 | $1.02M | Buy |
7,376
+200
| +3% | +$26.9K | 0.08% | 63 |
|
|
2022
Q4 | $973K | Buy |
7,176
+1,115
| +18% | +$140K | 0.08% | 58 |
|
|
2022
Q3 | $665K | Sell |
6,061
-1,585
| -21% | -$201K | 0.06% | 72 |
|
|
2022
Q2 | $1.01M | Buy |
7,646
+615
| +9% | +$80.7K | 0.09% | 49 |
|
|
2022
Q1 | $933K | Buy |
7,031
+1,808
| +35% | +$217K | 0.08% | 59 |
|
|
2021
Q4 | $608K | Sell |
5,223
-388
| -7% | -$45.7K | 0.05% | 80 |
|
|
2021
Q3 | $674K | Buy |
5,611
+1,200
| +27% | +$140K | 0.07% | 73 |
|
|
2021
Q2 | $528K | Buy |
4,411
+1,140
| +35% | +$125K | 0.05% | 84 |
|
|
2021
Q1 | $325K | Buy |
3,271
+531
| +19% | +$53.4K | 0.04% | 117 |
|
|
2020
Q4 | $274K | Buy |
2,740
+558
| +26% | +$59.1K | 0.04% | 117 |
|
|
2020
Q3 | $239K | Buy |
2,182
+431
| +25% | +$47.9K | 0.04% | 114 |
|
|
2020
Q2 | $185K | Buy |
1,751
+662
| +61% | +$68.4K | 0.04% | 122 |
|
|
2020
Q1 | $97K | Buy |
1,089
+532
| +96% | +$50.1K | 0.03% | 143 |
|
|
2019
Q4 | $56K | Buy |
557
+432
| +346% | +$40.7K | 0.02% | 162 |
|
|
2019
Q3 | $11K | Buy |
125
+7
| +6% | +$607 | ﹤0.01% | 220 |
|
|
2019
Q2 | $10K | Buy |
+118
| New | +$9.25K | ﹤0.01% | 250 |
|
Other funds holding AZN
Ellevest Inc's AZN Position: Q2 2026 in Review
Ellevest Inc increased its AstraZeneca (AZN) stake by 17% in Q2 2026, buying an estimated $182K and bringing the position to 6,725 shares worth $1.23M. The position accounts for 0.15% of the portfolio, ranked #104.
Ellevest Inc first reported a position in AZN in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.72M in Q2 2024. 1,511 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Ellevest Inc held 6,725 shares of AstraZeneca worth $1.23M as of Q2 2026.
- Ellevest Inc bought 967 AstraZeneca shares in Q2 2026, an estimated $182K.
- AstraZeneca made up 0.15% of Ellevest Inc's portfolio in Q2 2026, its #104 holding.
- Ellevest Inc first reported a position in AstraZeneca in Q2 2019 and has held it in 29 quarters since.
- Ellevest Inc's AstraZeneca position peaked at $1.72M in Q2 2024.
- 1,511 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.